新尧 周

Dr. 新尧 周


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
WZWeizhen Zeng
Weizhen Zeng
新周新尧 周
新尧 周
SYSULAN YU
SULAN YU
RLRuihua Liu
Ruihua Liu
CQChrystie Wan Ning Quek
Chrystie Wan Ning Quek
YFYun Feng
Yun Feng
Primary Sjögren’s syndrome (pSS) is a chronic, systemic autoimmune disease defined by exocrine gland hypofunction resulting in dry eyes and dry mouth. Despite increasing interest in biological therapies for pSS, achieving FDA-approval has been challenging due to numerous complications in the trials. The current literature lacks insight into a molecular-target-based approach to the development of biological therapies. This review focuses on novel research in newly defined drug targets and the latest clinical trials for pSS treatment. A literature search was conducted on ClinicalTrials.gov using the search term “Primary Sjögren’s syndrome”. Articles published in English between 2000 and 2021 were included. Our findings revealed potential targets for pSS treatment in clinical trials and the most recent advances in understanding the molecular mechanisms underlying the pathogenesis of pSS. A prominent gap in current trials is in overlooking the treatment of extraglandular symptoms such as fatigue, depression, and anxiety, which are present in most patients with pSS. Based on dryness and these symptom-directed therapies, emerging biological agents targeting inflammatory cytokines, signal pathways, and immune reaction have been studied and their efficacy and safety have been proven. Novel therapies may complement existing non-pharmacological methods of alleviating symptoms of pSS. Better grading systems that add extraglandular symptoms to gauge disease activity and severity should be created. The future of pSS therapies may lie in gene, stem-cell, and tissue-engineering therapies.

1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YGYinqiu Gao
Yinqiu Gao
新周新尧 周
新尧 周
XDXichen Dong
Xichen Dong
QJQing Jia
Qing Jia
SXShen Xie
Shen Xie
RPRan Pang
Ran Pang
Purpose. To determine the efficacy of electroacupuncture on recovering postanesthetic bladder function. Materials and Methods. Sixty‐one patients undergoing spinal anaesthesia were recruited and allocated into electroacupuncture or control group randomly. Patients in electroacupuncture group received electroacupuncture therapy whereas ones in control group were not given any intervention. Primary endpoint was incidence of bladder overdistension and postoperative urinary retention. Secondary endpoints included time to spontaneous micturition, voided volume, and adverse events. Results. All patients (31 in electroacupuncture group and 30 in control group) completed the evaluation. During postoperative follow‐up, patients in electroacupuncture group presented a significant lower proportion of bladder overdistension than counterparts in control group (16.1% versus 53.3%, P < 0.01). However, no significant difference was found in incidence of postoperative urinary retention between the two groups (0% versus 6.7%, P > 0.05). Furthermore, a shorter time to spontaneous micturition was found in electroacupuncture group compared to control group (228 min versus 313 min, P < 0.001), whereas urine volume and adverse events had no significant difference between the two groups. Conclusions. Electroacupuncture reduced the proportion of bladder overdistension and shortened the time to spontaneous micturition in patients undergoing spinal anesthesia. Electroacupuncture may be a therapeutic strategy for postanesthetic bladder dysfunction.

19 January 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
QJQuan Jiang
Quan Jiang
HZHuadong Zhang
Huadong Zhang
RPRan Pang
Ran Pang
JCJinzhou Chen
Jinzhou Chen
ZLZhishun Liu
Zhishun Liu
新周新尧 周
新尧 周
Currently, feasible medical treatments are hitherto not satisfying to relieve pSS symptoms, which concerns numbers of clinical doctors. Acupuncture seems to be an alternative to treat pSS and conduces to good symptomatic results. However further research is necessary. This trial is to investigate the efficacy of acupuncture on improving the key symptoms of pSS, which are dryness, pain and fatigue (DPF). The study is designed as a randomized controlled trial of two arms with a single centre. We compare acupuncture with sham acupuncture on symptomatic improvements of pSS. A total of 120 pSS patients, aged at least 18, with DPF, will be randomly assigned to acupuncture or sham acupuncture groups, where they will have needle intervention for 8 weeks with 16 weeks of follow-up. Subjects will be assessed each time before interventions during the 8-week intervention, in week 8 after all interventions and in week 12, 16, 20 and 24 for follow-up with different measurements. The primary outcome are the proportions of subjects that have 30% or greater reduction in at least 2 out of 3 items of DPF in Numeric Analog Scale (NAS) scores (0 = the best, 10 = the severest), calculated between the baseline and the average scores of week 2 to 8. The secondary outcome are related to individual items of NAS scores, EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI), EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI), Schirmer test score and unstimulated salivary flow, serum Immunoglobulin G, A and M levels, Medical Outcome Study Short Form 36 Short-Form Health Survey (SF-36), Salivary glands ultrasounds, Hospital Anxiety and Depression (HAD) scale score. The secondary outcome scores are to be collected at baseline, in week 8, 16, and 24. Besides, individual items of NAS will also be collected in week 12 and 20. Moreover, subjects’ satisfaction and the proportion of the subjects who identified their allocation will also be measured and analyzed. This study will be the first randomized and controlled pilot trial of acupuncture on alleviating the symptoms of pSS with relatively long-term follow-up. The result of the study might offer a new option to treat pSS and might be a clinical proof that acupuncture has beneficial effects on pSS. ClinicalTrials.gov: NCT02691377 (February 20, 2016)

30 July 2023 in Oral Diseases
Verified
Journal Article
Open access
RLRuihua Liu
Ruihua Liu
YZYi Zhang
Yi Zhang
KLKesong Li
Kesong Li
HXHaodong Xu
Haodong Xu
ZCZengyu Cheng
Zengyu Cheng
QJQuan Jiang
Quan Jiang
Aim: The aim of the study was to observe the effect of acupuncture on regulating interleukin (IL)‐17, tumor necrosis factor (TNF)‐ɑ, and aquaporins (AQPs) in Sjögren's syndrome (SS) on patients and on non‐obese diabetic (NOD) models.Methods: Levels of anti‐AQP 1, 5, 8, and 9 antibodies, IL‐17, and TNF‐ɑ in the serum of SS patients were compared prior and following 20 acupuncture treatment visits during 8 weeks. While in murine model, five groups were divided to receive interventions for 4 weeks, including control, model, acupuncture, isoflurane, and hydroxychloroquine. The submaxillofacial gland index, histology, immunohistochemistry of AQP1, 5, salivary flow, together with IL‐17, and TNF‐ɑ expression in peripheral blood were compared among the groups.Results: Acupuncture reduced IL‐17, TNF‐ɑ, and immunoglobin A levels, and numeric analog scale of dryness in 14 patients with SS (p < 0.05). The salivary flow was increased, and the water intake decreased in NOD mice receiving acupuncture treatments. IL‐17 and TNF‐ɑ levels in peripheral serum were down‐regulated (p < 0.05) and AQP1, 5 expression in the submandibular glands up‐regulated in mice.Conclusion: The effect on relieving xerostomia with acupuncture may be achieved by up‐regulating the expression of AQP1. AQP5, down‐regulating levels of IL‐17 and TNF‐ɑ, and a decrease in inflammation of glands.

18 August 2011 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
QJQuan Jiang
Quan Jiang
新周新尧 周
新尧 周
LWLei Wang
Lei Wang
WYWei Yu
Wei Yu
PWPing Wang
Ping Wang
XTXiao-Po Tang
Xiao-Po Tang

1 August 2023
Verified
Journal Article
Closed access
FPFengtao Pang
Fengtao Pang
KLKesong Li
Kesong Li
YZYi Zhang
Yi Zhang
TTTang Tang
Tang Tang
新周新尧 周
新尧 周